Newsletter | January 30, 2021

01.30.21 -- New Drug Combination Shows Promise As Powerful Treatment For AML

 
Sponsor
Industry Insights
Debunking Myths And Misconceptions About Softgels

Here, we take a look at some common myths about softgels and explore why drug developers may want to reconsider their go-to delivery methods.

Success At Speed: Best Practices To Accelerate Vaccine Development

In a pandemic, speed to market is as critical as safety and efficacy. Sartorius brought their top minds in vaccine manufacturing together and discussed best practices to accelerate processes from vaccine development to distribution. Success at Speed is a collection of articles documenting each step in the journey and how technology and partnerships make the difference in getting medicines to patients when they need them most. Download the eBook now.

QbD For Process Development, Scale-Up Of A Novel ALS Drug Product

A stepwise approach to Quality by Design (QbD), which drives consistent quality into manufacturing, became integral to the success of Amylyx's AMX-0035 campaign. 

An Engineered Platform For High-Loaded Dosage Forms Of Amorphous Solid Dispersions

This poster outlines a novel engineered platform for the formulation of high-active-loading oral solid dosage forms containing amorphous solid dispersions (ASDs) of a rapidly crystallizing drug with a low glass-transition temperature (Tg).

Flow Chemistry: Scale-Up Solution For Modern API Manufacturing

Once deemed an “experts-only” approach to chemical synthesis, flow chemistry is a cost-efficient technique growing in popularity that can increase safety and flexibility and improve product quality.

Enhanced Host Cell Protein Analysis In Biologics Manufacturing

iEnzyme-Linked Immunosorbent Assays (ELISAs) to monitor host cell protein levels are challenging. This article illustrates an enhanced anti-host cell protein antibody coverage analysis method solution.

Most Popular News
Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.